ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov.

85,013 comparisons

Most participants first33,758 with no events in either group come last3,561 to 3,580 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
IBD Cases With Mental Health Condition vs IBD Cases Without Mental Health Condition (Reference Group): Stream 2: Relative Risk of Low Mood (Emotional Function)63 of 295

119 of 1,648

14.1 points

9.6 to 19.3

1,943NCT05206734

Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health

IBD Cases With Mental Health Condition vs IBD Cases Without Mental Health Condition (Reference Group): Stream 2: Relative Risk of Sleep Disturbance (Quality of Life Indicator)26 of 295

83 of 1,648

3.8 points

0.8 to 7.7

1,943NCT05206734

Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health

Fluzone Quadrivalent Vaccine, 0.25-mL vs Fluzone Quadrivalent Vaccine, 0.5-mL: serious adverse events5 of 949

5 of 992

0.0 points

-0.7 to 0.8

1,941NCT02915302

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children

SOC Arm vs Enhanced Arm: Number of Participants Undergoing HIV Testing Within 12 Months361 of 918

552 of 1,021

-14.7 points

-19.1 to -10.3

1,939NCT04429061

Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ

Intervention Arm vs Control Arm: deaths from any cause9 of 969

12 of 969

-0.3 points

-1.3 to 0.7

1,938NCT01737281

Proactive Outreach for Smokers in VA Mental Health

Intervention Arm vs Control Arm: serious adverse events39 of 969

28 of 969

1.1 points

-0.5 to 2.8

1,938NCT01737281

Proactive Outreach for Smokers in VA Mental Health

Message-based Outreach Intervention (MBI) for Survivors vs Standard Outreach for Survivors: Number of Survivors Using Website Access Code147 of 969

202 of 969

-5.7 points

-9.1 to -2.3

1,938NCT04927013

Connecting Families to Overcome Ovarian Cancer

Roflumilast 500 µg vs Placebo: serious adverse events249 of 968

285 of 967

-3.7 points

-7.7 to 0.2

1,935NCT01329029

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)

TC Arm vs TAC Arm: deaths from any cause110 of 969

88 of 965

2.2 points

-0.5 to 4.9

1,934NCT00493870

TAC Versus TC for Adjuvant Breast Cancer

TC Arm vs TAC Arm: serious adverse events264 of 969

330 of 965

-7.0 points

-11.0 to -2.8

1,934NCT00493870

TAC Versus TC for Adjuvant Breast Cancer

Arm A: FAC vs Arm B: FAC-wP: Overall Survival (OS) Event40 of 974

31 of 951

0.8 points

-0.9 to 2.6

1,925NCT00129389

FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

Arm A: FAC vs Arm B: FAC-wP: deaths from any cause40 of 974

31 of 951

0.8 points

-0.9 to 2.6

1,925NCT00129389

FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

Arm A: FAC vs Arm B: FAC-wP: Disease-free Survival (DFS) Event98 of 974

71 of 951

2.6 points

0.1 to 5.1

1,925NCT00129389

FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

Arm A: FAC vs Arm B: FAC-wP: serious adverse events60 of 974

61 of 951

-0.3 points

-2.5 to 1.9

1,925NCT00129389

FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

BioNIR vs Resolute: deaths from any cause5 of 958

2 of 961

0.3 points

-0.3 to 1.0

1,919NCT01995487

Study of BioNIR Drug Eluting Stent System in Coronary Stenosis

Transdisciplinary Approach vs Multidisciplinary Approach: Wandering38 of 521

98 of 1,393

0.3 points

-2.2 to 3.1

1,914NCT03442322

Optimizing Care for Patients With Dementia

Transdisciplinary Approach vs Multidisciplinary Approach: Rejection of Care59 of 521

217 of 1,393

-4.3 points

-7.4 to -0.7

1,914NCT03442322

Optimizing Care for Patients With Dementia

Arm I vs Arm II: deaths from any cause100 of 959

100 of 954

-0.1 points

-2.8 to 2.7

1,913NCT00754845

Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy

Arm I vs Arm II: serious adverse events15 of 959

19 of 954

-0.4 points

-1.7 to 0.8

1,913NCT00754845

Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy

Transdisciplinary Approach vs Multidisciplinary Approach: Behavioral Symptoms68 of 521

232 of 1,392

-3.6 points

-6.9 to 0.1

1,913NCT03442322

Optimizing Care for Patients With Dementia

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Code

Show the call in
curl "https://conductscience.org/api/comparisons/v1?page=179"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=179

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT05206734-1a8fcd84",
        "title": "IBD Cases With Mental Health Condition vs IBD Cases Without Mental Health Condition (Reference Group): Stream 2: Relative Risk of Low Mood (Emotional Function)",
        "summary": "63 of 295 against 119 of 1648; risk difference 14.1 points, 95% interval 9.6 to 19.3; NCT05206734, Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health",
        "record": "/library/comparisons/NCT05206734-1a8fcd84",
        "nct_id": "NCT05206734",
        "kind": "outcome",
        "participants": 1943,
        "risk_difference": {
          "value": 0.14135058416982063,
          "lower": 0.09634498259237718,
          "upper": 0.19294668666923143
        },
        "group_1": "63 of 295",
        "group_2": "119 of 1,648",
        "difference": "14.1 points",
        "interval": "9.6 to 19.3",
        "trial_title": "Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health"
      },
      {
        "id": "NCT05206734-28de7d4d",
        "title": "IBD Cases With Mental Health Condition vs IBD Cases Without Mental Health Condition (Reference Group): Stream 2: Relative Risk of Sleep Disturbance (Quality of Life Indicator)",
        "summary": "26 of 295 against 83 of 1648; risk difference 3.8 points, 95% interval 0.8 to 7.7; NCT05206734, Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health",
        "record": "/library/comparisons/NCT05206734-28de7d4d",
        "nct_id": "NCT05206734",
        "kind": "outcome",
        "participants": 1943,
        "risk_difference": {
          "value": 0.03777151555043607,
          "lower": 0.008110077645064606,
          "upper": 0.07682683008585464
        },
        "group_1": "26 of 295",
        "group_2": "83 of 1,648",
        "difference": "3.8 points",
        "interval": "0.8 to 7.7",
        "trial_title": "Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=180",
  "request_id": "WjYpXe7r83lHXZD_"
}

Ask about these results. The first 10 go in the prompt.

About this data
Holds
85,013 comparisons
From ClinicalTrials.gov. Counted 10 Nov 2026.
Release
23 Mar 2026
trial-comparisons-2026-03-23-0.1.0
Checked
20 of 20 review comparisons traced to ClinicalTrials.gov, and all 510,078 numbers calculated again apart from the builder agree
Access
Open
No account. 60 calls a minute from one address.

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

Opens sequences.conductscience.org

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?